ArticleAcute medicine & surgery
Bronchoalveolar Lavage Fluid Analysis in Severe COVID-19: Insights Into Cellular and Microbiological Characteristics.
Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bronchoalveolar Lavage Fluid Analysis in Severe COVID-19: Insights Into Cellular and Microbiological Characteristics.Acute medicine & surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to describe bronchoalveolar lavage fluid (BALF) findings in cases of refractory respiratory failure, despite standard treatment, among patients with severe coronavirus disease 2019 (COVID-19), compare BALF findings between patients with mechanical ventilation (MV) weaning success and those with failure within 28 days, and evaluate the safety and impact on respiratory mechanics of BALF examination in patients with severe COVID-19. Methods: This study was conducted at the Department of Emergency Medicine, Sapporo Medical University, Japan. We included 21 patients with concurrent severe COVID-19 and refractory respiratory failure who could not be weaned from MV despite standard treatment. We compared BALF cellular composition and culture results between patients who were successfully weaned from MV within 28 days and those who were not. Respiratory mechanics before and after BALF collection were also evaluated. Results: BALF analysis revealed a mixed cellular pattern with a median total cell count of 174/μL (interquartile range [IQR], 104-400/μL). The successfully weaned group showed significantly higher macrophage percentages (24.7% vs. 3.5%, Conclusions: BALF analysis revealed a mixed cellular pattern. The successfully weaned group had significantly higher macrophage percentages and counts. BALF examination can be safely performed in patients with severe COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.